 | • レポートコード：MRC2303D042 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：化学＆部品 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界のハイドロキシアパタイト市場規模が、2022年に2,250.19百万ドルから、2027年3,086.05百万ドルに達し、予測期間中に年平均6.52%で拡大すると推測しています。本書は、ハイドロキシアパタイトの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（ナノサイズ、マイクロサイズ、マイクロメートルサイズ以上）分析、用途別（デンタルケア、形成外科、整形外科、その他）分析、地域別（中国、インド、日本、韓国、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、ブラジル、アルゼンチン、サウジアラビア、南アフリカ）分析、競争状況、市場機会・将来の動向などをまとめています。なお、主要参入企業として、APS Materials Inc.、Berkeley Advanced Biomaterials (GNI Group Ltd)、Bio-Rad Laboratories Inc.、CGbio、FLUIDINOVA、Granulab Sdn. Bhd. (KPower Berhad)、HOYA Technosurgical Corporation (HOYA Corporation)、SANGI CO. LTD、SigmaGraft Biomaterials、Taihei Chemical Industrial Co. Ltd、Zimmer Biometなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のハイドロキシアパタイト市場規模：種類別 - ナノサイズのハイドロキシアパタイト市場規模 - マイクロサイズのハイドロキシアパタイト市場規模 - マイクロメートルサイズ以上のハイドロキシアパタイト市場規模 ・世界のハイドロキシアパタイト市場規模：用途別 - デンタルケアにおける市場規模 - 形成外科における市場規模 - 整形外科における市場規模 - その他用途における市場規模 ・世界のハイドロキシアパタイト市場規模：地域別 - アジア太平洋のハイドロキシアパタイト市場規模 中国のハイドロキシアパタイト市場規模 インドのハイドロキシアパタイト市場規模 日本のハイドロキシアパタイト市場規模 … - 北米のハイドロキシアパタイト市場規模 アメリカのハイドロキシアパタイト市場規模 カナダのハイドロキシアパタイト市場規模 メキシコのハイドロキシアパタイト市場規模 … - ヨーロッパのハイドロキシアパタイト市場規模 ドイツのハイドロキシアパタイト市場規模 イギリスのハイドロキシアパタイト市場規模 フランスのハイドロキシアパタイト市場規模 … - 南米/中東のハイドロキシアパタイト市場規模 ブラジルのハイドロキシアパタイト市場規模 アルゼンチンのハイドロキシアパタイト市場規模 サウジアラビアのハイドロキシアパタイト市場規模 … - その他地域のハイドロキシアパタイト市場規模 ・競争状況 ・市場機会・将来の動向 |
The Global Hydroxyapatite Market size is estimated to be at USD 2,250.19 million in 2022 and the market is projected to register USD 3,086.05 million by 2027, registering a CAGR of ~6,52% during 2022-2027.
The market was negatively impacted by COVID-19 in 2020. Presently the market has now reached pre-pandemic levels.
Key Highlights
- The major factor driving the growth of the hydroxyapatite market are rising interest in prosthetic applications and increasing demand from the orthopedic segment.
- On the flip side, the high expenditure of implants is anticipated to impact the growth of the market studied.
- North America is expected to be the largest market for hydroxyapatite and its products globally during the forecast period.
Hydroxyapatite Market Trends
Orthopedic Segment to Dominate the Hydroxyapatite Market
- Hydroxyapatite (HAp) is a fundamental calcium phosphate existing as the primary material of bones, teeth, and minerals, normally with high bi-affinity. Its composition promotes osseointegration between bone and orthopedic implants, allowing for the ultimate structural and functional connection. Because of its versatility, hydroxyapatite is becoming increasingly popular as an implant coating.
- Because of the similar nature between nano-hydroxyapatite and mineralized bone, HAp powders have a high affinity to hard tissues, and they bond chemically with the host tissue bringing about improved biological performance. These items are utilized to produce bone graft substitutes, such as porous granules and block scaffolds for bone recovery.
- With the improvement of nanotechnology, a significant effect on materials science has been taken note of. The use of nano-hydroxyapatite (nano-HAp) is on rising as a biomaterial in orthopedic applications because of its similarity in size, crystallography, and chemical composition with human hard tissue. Bones, to a great extent, are made of this type of mineral.
- According to the WHO (World Health Organization), by 2030, one out of every six persons on the planet will be 60 years old or older. The number of people aged 60 and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of adults aged 60 and up will have doubled (2.1 billion). Between 2020 and 2050, the number of people aged 80 and more is predicted to triple, reaching 426 million.
- Although the movement in population distribution toward older ages, known as population aging, began in high-income nations (for instance, in Japan, 30% of the population is already over 60 years old), it is currently low- and middle-income countries that are seeing the most change. Two-thirds of the world’s population over the age of 60 will reside in low- and middle-income countries by 2050.
- With the growing aged population and health issues in several countries across the world, the demand for orthopedic is expected to increase during the forecast period, thus, increasing the demand for hydroxyapatite.
- All the aforementioned factors are expected to drive the demand for hydroxyapatite from the orthopedic application during the forecast period.
North America Region to Dominate the Market Studied
- The North American region holds a prominent share in the hydroxyapatite market globally and is expected to dominate the market during the forecast timeline due to high investment and better healthcare infrastructure.
- In 2021, the United States health care spending grew by 4.2%, reaching USD 4.3 trillion after registering a growth of 9.7% in 2020. As a share of the nation’s Gross Domestic Product, health spending accounted for 18.8%.
- Furthermore, according to World Bank data, the population above 65 years of age in the United States stood at around 16.6% of the total population, which requires more medical attention for tooth decay and gum problems as well as a rising risk of arthritis among aged people.
- Government data showed that 75% of Canadians visit a dental clinic annually, and 86% do so at least once every two years. Thus, 84% of Canadians report their oral health as good or excellent.
- However, 34% of dentate Canadians aged 6-79 years had some treatment that needs to be identified. 1 out of 3 Canadians has a need, and only 1 out of 6 says they cannot address this need for financial reasons.
- Mexico is among the world’s most popular medical tourism destinations. The overall cost of living is low relative to the United States. That means hospitals and clinics can charge much less for medical procedures. Many Americans who lack health insurance thus make the short trip across the border to Mexico for treatment.
- Thus, the rising demand from various segments is expected to drive the market studied in the region during the forecast timeframe.
Hydroxyapatite Market Competitor Analysis
The market for hydroxyapatite is partially fragmented. Some of the players in the market include Zimmer Biomet, HOYA Technosurgical Corporation (HOYA Corporation), CGbio, Bio-Rad Laboratories Inc., and Taihei Chemical Industrial Co. Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Rising Interest in Prosthetic Applications
4.1.2 Increasing Demand from the Orthopedic Segment
4.2 Restraints
4.2.1 High Expenditure of Implants
4.2.2 Other Restraints
4.3 Industry Value Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Degree of Competition
5 MARKET SEGMENTATION
5.1 Type
5.1.1 Nano-sized
5.1.2 Micro-sized
5.1.3 Greater than Micrometers
5.2 Application
5.2.1 Dental Care
5.2.2 Plastic Surgery
5.2.3 Orthopedic
5.2.4 Other Applications
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 France
5.3.3.4 Italy
5.3.3.5 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle-East
6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share(%)**/Ranking Analysis
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 APS Materials Inc.
6.4.2 Berkeley Advanced Biomaterials (GNI Group Ltd)
6.4.3 Bio-Rad Laboratories Inc.
6.4.4 CGbio
6.4.5 FLUIDINOVA
6.4.6 Granulab Sdn. Bhd. (KPower Berhad)
6.4.7 HOYA Technosurgical Corporation (HOYA Corporation)
6.4.8 SANGI CO. LTD
6.4.9 SigmaGraft Biomaterials
6.4.10 Taihei Chemical Industrial Co. Ltd
6.4.11 Zimmer Biomet
7 MARKET OPPORTUNITIES AND FUTURE TRENDS